Hyster-Yale (HY) recently posted a 2.78% daily gain, outperforming the S&P 500, but its shares have declined 5.34% over the past month, significantly underperforming its sector and the broader market. The company faces a challenging outlook, with consensus estimates projecting a 96.91% year-over-year decline in quarterly EPS to $0.03 and a 5.95% revenue drop to $955.69 million. This bearish sentiment is reinforced by a Zacks Rank of #5 (Strong Sell), a premium forward P/E of 47.96 compared to its industry average of 23.4, and its industry ranking in the bottom 8% of all sectors.
Despite a recent single-day outperformance where Hyster-Yale (HY) gained 2.78% against the S&P 500's 0.85% rise, the stock's one-month performance shows a significant -5.34% decline, starkly underperforming its sector and the broader market. The fundamental outlook appears exceptionally challenging, with consensus estimates for the upcoming quarter pointing to a 96.91% year-over-year collapse in EPS to $0.03 and a 5.95% revenue contraction to $955.69 million. This negative trend is projected to persist for the full year, with anticipated annual EPS and revenue declines of 91.65% and 12.59%, respectively. The bearish thesis is further substantiated by a Zacks Rank of #5 (Strong Sell) and the company's position within an industry ranked in the bottom 8% of all sectors. Critically, HY trades at a forward P/E ratio of 47.96, a significant premium to its industry's average of 23.4, indicating a valuation that appears disconnected from its severely deteriorating earnings profile and stagnant analyst estimates.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly negative
Sentiment Score
-0.80
Ticker Sentiment